series-c-plus
Stage
1
Investors
About
Aileron Therapeutics develops stapled peptide therapeutics designed to target and treat diseases by modulating intracellular protein-protein interactions that are difficult to drug with conventional small molecules.
Explore Aileron Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.